EXACT SCIENCES CORP Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 39 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-10-11: Reporting owner Cunningham Everett; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2023-10-11: Reporting owner Cunningham Everett; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2023-08-04: Reporting owner Baranick Brian; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2023-02-27: Reporting owner Elliott Jeffrey Thomas; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-10-11 | Cunningham Everett Officer (Chief Commercial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,003 20,004 owned after | $0.00 | 2023-10-13 | |
| 2023-10-11 | Cunningham Everett Officer (Chief Commercial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,501 7,501 owned after | $0.00 | 2023-10-13 | |
| 2023-08-04 | Baranick Brian Officer (Gen. Mgr., Precision Oncology) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,712 2,712 owned after | $0.00 | 2023-08-08 | |
| 2023-02-27 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,700 17,102 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,437 0 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | Cunningham Everett Officer (Chief Commercial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,677 23,034 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | Herriott James Officer (General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,647 4,943 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | Herriott James Officer (General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −240 0 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | ORVILLE JACOB A Officer (General Manager, Screening) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,954 11,863 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | COWARD D SCOTT Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,931 0 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | COWARD D SCOTT Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,263 0 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | Condella Sarah Officer (EVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,954 11,863 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | Condella Sarah Officer (EVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,357 0 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | Baranick Brian Officer (Gen. Mgr., Precision Oncology) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,954 11,863 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,180 39,541 owned after | $0.00 | 2023-03-01 | |
| 2023-02-27 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,312 0 owned after | $0.00 | 2023-03-01 | |
| 2023-02-24 | ORVILLE JACOB A Officer (General Manager, Screening) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,899 18,899 owned after | $0.00 | 2023-02-28 | |
| 2023-02-24 | Baranick Brian Officer (Gen. Mgr., Precision Oncology) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,899 18,899 owned after | $0.00 | 2023-02-28 | |
| 2023-02-24 | Herriott James Officer (General Counsel) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,560 7,560 owned after | $0.00 | 2023-02-28 | |
| 2023-02-24 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +72,572 72,572 owned after | $0.00 | 2023-02-28 | |
| 2023-02-24 | Cunningham Everett Officer (Chief Commercial Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,167 21,167 owned after | $0.00 | 2023-02-28 | |
| 2023-02-24 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,167 21,167 owned after | $0.00 | 2023-02-28 | |
| 2023-02-24 | Condella Sarah Officer (EVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,119 15,119 owned after | $0.00 | 2023-02-28 | |
| 2023-02-21 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,374 20,747 owned after | $0.00 | 2023-02-23 | |
| 2023-02-21 | Herriott James Officer (General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −865 1,728 owned after | $0.00 | 2023-02-23 | |
| 2023-02-21 | ORVILLE JACOB A Officer (General Manager, Screening) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,649 0 owned after | $0.00 | 2023-02-23 | |
| 2023-02-21 | ORVILLE JACOB A Officer (General Manager, Screening) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,248 4,495 owned after | $0.00 | 2023-02-23 | |
| 2023-02-21 | Condella Sarah Officer (EVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,248 4,495 owned after | $0.00 | 2023-02-23 | |
| 2023-02-21 | COWARD D SCOTT Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,248 4,495 owned after | $0.00 | 2023-02-23 | |
| 2023-02-21 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,112 6,225 owned after | $0.00 | 2023-02-23 | |
| 2023-02-21 | Baranick Brian Officer (Gen. Mgr., Precision Oncology) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,729 3,458 owned after | $0.00 | 2023-02-23 | |
| 2023-02-14 | Herriott James Officer (General Counsel) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −883 883 owned after | $0.00 | 2023-02-16 | |
| 2023-02-14 | Condella Sarah Officer (EVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,030 2,031 owned after | $0.00 | 2023-02-16 | |
| 2023-02-14 | ORVILLE JACOB A Officer (General Manager, Screening) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,030 2,031 owned after | $0.00 | 2023-02-16 | |
| 2023-02-14 | COWARD D SCOTT Director | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,972 3,972 owned after | $0.00 | 2023-02-16 | |
| 2023-02-14 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,972 3,972 owned after | $0.00 | 2023-02-16 | |
| 2023-02-14 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −31,132 31,132 owned after | $0.00 | 2023-02-16 | |
| 2023-02-10 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Performance Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,579 0 owned after | $0.00 | 2023-02-14 | |
| 2023-02-10 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Performance Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,705 0 owned after | $0.00 | 2023-02-14 |